A New Treatment Option for Amyotrophic Lateral Sclerosis: Edaravone

Journal Title: UNKNOWN - Year 2018, Vol 24, Issue 1

Abstract

.

Authors and Affiliations

Erdi Şahin

Keywords

Related Articles

Assessment of Serum Uric Acid Levels According to Sex and Stage for Patients with Alzheimer-type Dementia

Objective: The aim of this study was to identify serum uric acid (UA) concentrations according to disease stage in patients with Alzheimer-type dementia (AD), and to collect data related to the hypothesis that oxidative...

Evaluation of Seizure After Stroke in Stroke Unit

Objective: Patients with stroke may experience epileptic seizures as acute phase (usually defined as the first 15 days) or late phase complications. Risk factors are young age, male sex, cortical involvement and hemorrha...

Efficiency of Intravenous Thrombolytic Therapy in Isolated Middle Cerebral Artery Occlusions: A Computed Tomography Angiography Study

Objective: We aimed to evaluate the outcomes of two groups of patients with acute ischemic stroke who were treated with intravenous recombinant tissueplasminogen activator (IV rt-PA); those with isolated middle cerebral...

Download PDF file
  • EP ID EP277538
  • DOI 10.4274/tnd.90698
  • Views 66
  • Downloads 0

How To Cite

Erdi Şahin (2018). A New Treatment Option for Amyotrophic Lateral Sclerosis: Edaravone. UNKNOWN, 24(1), 105-106. https://europub.co.uk/articles/-A-277538